Meds, Mind, Body & Benefits > Research News & Studies

J&J's HIV vaccine fails phase 2b


From the August 31, edition of "Fierce Biotech:"


The wait for an HIV vaccine goes on. Johnson & Johnson, having seen peers including Merck swing at HIV and miss, has reported the failure of a vaccine based on similar technology to its COVID-19 jab to protect women from infection with the virus.


Link to story:

Had no idea J&J had a vaccine for HIV.. but did see the story this morning in the NYT..

I'm looking forward to seeing results from Modena's mRNA HIV vaccine trials.


[0] Message Index

Go to full version